Carcinoembryonic Antigen Monoclonal Antibody(10E1)

This gene encodes a cell surface glycoprotein that represents the founding member of the carcinoembryonic antigen (CEA) family of proteins. The encoded protein is used as a clinical biomarker for gastrointestinal cancers and may promote tumor development through its role as a cell adhesion molecule. Additionally, the encoded protein may regulate differentiation, apoptosis, and cell polarity. This gene is present in a CEA family gene cluster on chromosome 19. Alternative splicing results in multiple transcript variants.

The CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY(10E1) is a highly specialized product that has been developed to target and detect the presence of carcinoembryonic antigen (CEA) in biological samples. This monoclonal antibody is produced using advanced biotechnological techniques and is characterized by its high specificity and sensitivity towards CEA.

The CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY(10E1) is an essential tool for researchers and clinicians who are involved in the diagnosis and treatment of various types of cancer. It can be used in a wide range of applications, including immunohistochemistry, flow cytometry, and ELISA assays.

This product is manufactured to the highest quality standards and undergoes rigorous testing to ensure its purity, potency, and consistency. It is supplied in a convenient format that is easy to use and can be stored for extended periods without losing its activity.

In summary, the CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY(10E1) is a reliable and effective tool for the detection and quantification of CEA in biological samples. Its high specificity and sensitivity make it an indispensable product for cancer research and diagnosis.